Real world costs and cost-effectiveness of rituximab for diffuse large B-cell lymphoma patients: a population-based analysis
Khor S, Beca J, Krahn M, Hodgson D, Lee L, Crump M, Bremner KE, Luo J, Mamdani M, Bell CM, Sawka C, Gavura S, Sullivan T, Trudeau M, Peacock S, Hoch JS. BMC Cancer. 2014; 14:586. Epub 2014 Aug 12.